Trexquant Investment’s T2 Biosystems, Inc TTOO Stock Holding History

Trexquant Investment’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6	Closed	-$216K	–	1376
2018 Q3	$216K	Buy	+6	New	+$198K	0.02%	800

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Trexquant Investment's TTOO Position: Q4 2018 in Review

Trexquant Investment sold out of T2 Biosystems, Inc (TTOO) in Q4 2018, closing a stake of 6 shares — an estimated $216K sold.

Trexquant Investment first reported a position in TTOO in Q3 2018 and held it in 1 quarter. The position peaked at $216K in Q3 2018. 84 funds tracked by Wall St. Rank hold TTOO as of Q4 2018.

Trexquant Investment reported no remaining T2 Biosystems, Inc position as of Q4 2018 after selling out during the quarter.
Trexquant Investment sold 6 T2 Biosystems, Inc shares in Q4 2018, an estimated $216K.
Trexquant Investment first reported a position in T2 Biosystems, Inc in Q3 2018 and held it in 1 quarter.
Trexquant Investment's T2 Biosystems, Inc position peaked at $216K in Q3 2018.
84 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2018.

Based on Trexquant Investment's 13F filing for Q4 2018, filed 13 Feb 2019.